Last reviewed · How we verify
Xiapex
At a glance
| Generic name | Xiapex |
|---|---|
| Also known as | Xiaflex, XIAPEX® - Pfizer UK, clostridium histolyticum |
| Sponsor | University Hospital, Akershus |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Can the Number of Skin Tears be Reduced, by Prophylactic Treatment of the Skin in Dupuytrens Contracture Treated With Collagenase? (NA)
- Trial Comparing Treatment Strategies in Dupuytren's Contracture (PHASE4)
- Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures (EARLY_PHASE1)
- Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF (PHASE4)
- Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum
- Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
- An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease (PHASE3)
- Post Approval Commitment Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |